VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Pharmaceutical
Shares in German life sciences company Merck KGaA had climbed by more than 3% to 95.10 euros ($113) by lunchtime on Tuesday after the firm announced it was preparing strategic options for its Consumer Health business. 5 September 2017
Biotechnology
US gene therapy developer Abeona Therapeutics is set to start trading on Monday with a share price worth around $13.60, more than 50% higher than it was a week ago. 4 September 2017
Pharmaceutical
Japanese conglomerate Fujifilm Holdings, best known for its photography and imaging operations, also has a sizeable business in healthcare, which it is hoping to expand. 31 August 2017
Biotechnology
Nordic life sciences investment firm Karolinska Development is set to receive a significant chunk of shares in Xspray Pharma due to the product development company’s upcoming listing on Nasdaq First North. 25 August 2017
Biotechnology
Scientists at the University of Massachusetts Medical School (UMMS) have spun out a gene therapy research program into a private company. 25 August 2017
Biotechnology
Renewed talk of a takeover prompted shares in US biopharma Paratek Pharmaceuticals to rise by 27% on Wednesday. 24 August 2017
Biotechnology
The Medicines Manufacturing Industry Partnership has issued a report seeking government support for the building of four new ‘centres of excellence’ for medicines manufacturing across the UK. 23 August 2017
Biotechnology
Merck Ventures, the venture capital arm of the German pharmaceutical group Merck KGaA has invested in the UK-based immuno-oncology company Macrophage Pharma, completing a previously announced series A financing round. 23 August 2017
Generics
Shares of Jordan-based Hikma Pharmaceuticals (LSE: HIK) dropped 11.8% to £11.75 in early London trading today, after it reported its interim results for the six months ended June 30, 2017 and expansion of a marketing deal with Japan’s largest drugmaker. 17 August 2017
Biotechnology
Goldman Sachs cited Biogen’s experimental Alzheimer’s drug aducanumab as a major reason for its addition of the US biotech company to the investment bank’s Equity Conviction List. 17 August 2017
Biotechnology
Australian biotech firm CSL Limited today announced a net profit after tax (NPAT) of $1,337 million (all figures US dollars) for the 12 months ended June 30, 2017. 16 August 2017
Biotechnology
Beijing-based BeiGene has announced it will issue an additional 2,465,000 shares in a follow-on public offering that is expected to raise up to $175 million. 11 August 2017
Biotechnology
Privately-held Apellis Pharmaceuticals, a biotech company based in Kentucky, USA, has closed a financing round aimed at raising $60 million to further clinical development. 11 August 2017
Biotechnology
Danish biotech firm Genmab dwarfed its 2016 sales with both its half-year and quarterly figures, which were presented on Wednesday. 10 August 2017
Pharmaceutical
Switzerland’s Basilea Pharmaceutica announced today its financial results for the first half of financial year 2017, with the news first sending the shares higher, but they were down 2.1% at 83.35 Swiss francs by late afternoon. 10 August 2017
Generics
Netherlands-incorporated Mylan’s (Nasdaq: MYL) shares were down 7.9% at $31.79 in pre-market trading, after the company released second-quarter 2017 financial results which missed expectations, and reduced its full-year guidance. 9 August 2017
Pharmaceutical
Strong second quarter results were posted by Danish CNS specialist Lundbeck today, with revenue of 4.3 billion Danish kroner ($663 million), a touch higher than the Financial Times’ consensus forecast of 4.17 billion kroner. 9 August 2017
Pharmaceutical
For the second quarter in a row, the results of Danish diabetes giant Novo Nordisk have sent the company’s share price soaring. 9 August 2017
Pharmaceutical
Beleaguered Canadian firm Valeant Pharmaceuticals International reported a 7.8 % decline in revenues to $2.23 billion in the second quarter of 2017, hurt by lower volume and pricing of its generic and neurology products. 8 August 2017
Pharmaceutical
There were again a number of important financial results reports in the past week, with three – Pfizer, Shire and Teva Pharmaceutical Industries – attracting most external comments. Clovis Oncology’s deal with Bristol-Myers Squibb on its cancer drug Rubraca had a negative impact on the former’s, share price and - for a change in recent times – there was good news for AstraZeneca with regard to its cancer drug Imfinzi. 7 August 2017
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze